Evidence map›Paper›PMID 41431546›Full record

ArticleCureus2025

High Readmission Rate in a Patient With Chronic Heart Failure, End-Stage Renal Disease, and Chronic Pulmonary Obstructive Disease.

Akila B Jayanthan, Peter DesRochers, Sabrina Shafi, Roxana Lazarescu

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Akila B JayanthanInternal Medicine, Saba University School of Medicine, The Bottom, BES.
Peter DesRochersInternal Medicine, Medical University of the Americas, Potworks, KNA.
Sabrina ShafiInternal Medicine, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, USA.
Roxana LazarescuInternal Medicine, Wyckoff Heights Medical Center, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hospital readmission is common for patients with multiple chronic comorbidities, but it is a burden to both patients and healthcare systems. While this is a multifactorial issue, it is important to identify some of the reasons that contribute to high readmission rates and advocate for concrete interventions that can be implemented. We report the case of a 68-year-old female with congestive heart failure with severely reduced ejection fraction, chronic obstructive pulmonary disease requiring home oxygen, and end-stage renal disease on hemodialysis who was readmitted more than 30 times in the previous year. In the last readmission, the patient was admitted for acute on chronic respiratory failure, which improved with hemodialysis during the hospital stay. Beyond her complex comorbidities, the patient's recurrent admissions were further complicated by restricted mobility, limited home health aid hours, and treatment noncompliance. Strategies such as consistent professional interpreter use, patient-specific medical education, pharmacy delivery programs, and medically adapted transportation may help reduce hospitalizations. The causes of high readmission rates are multifactorial. This case highlights numerous techniques to increase patient compliance and thereby reduce readmissions. Patient-centered strategies, combined with system-level improvements, are needed to address the complexities faced by patients with multiple comorbidities. Further research is needed to identify additional strategies that reduce readmissions, improve quality of life, and lower morbidity and mortality.

Indexed as

chf exacerbationchronic heart failure (chf)congestive heart failure (chf)copd: chronic obstructive pulmonary diseaseend-stage renal disease (esrd)

Identifiers

PMID41431546
PMCPMC12718480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.